127 related articles for article (PubMed ID: 35489734)
1. Usefulness of Surgical Staging of Gastric Cancer in Neoadjuvant Chemotherapy Candidates: A Single-center Retrospective Study.
Komori K; Kano K; Yamada T; Watanabe H; Takahashi K; Maezawa Y; Fujikawa H; Numata M; Aoyama T; Tamagawa H; Yukawa N; Rino Y; Masuda M; Ogata T; Oshima T
Anticancer Res; 2022 May; 42(5):2719-2725. PubMed ID: 35489734
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Survival Between ypStage and pStage in Gastric Cancer.
Komori K; Yamada T; Ando S; Hashimoto I; Watanabe H; Maezawa Y; Fujikawa H; Sawazaki S; Numata M; Aoyama T; Yukawa N; Rino Y; Saito A; Ogata T; Oshima T
Anticancer Res; 2024 Jun; 44(6):2661-2670. PubMed ID: 38821586
[TBL] [Abstract][Full Text] [Related]
3. [A multi-center retrospective study of perioperative chemotherapy for gastric cancer based on real-world data].
Ding XW; Zheng ZC; Zhao Q; Zhai G; Liang H; Wu X; Zhu ZG; Wang HJ; He QS; He XL; Du YA; Chen LC; Hua YW; Huang CM; Xue YW; Zhou Y; Zhou YB; Wu D; Fang XD; Dai YG; Zhang HW; Cao JQ; Li LP; Chai J; Tao KX; Li GL; Jie ZG; Ge J; Xu ZF; Zhang WB; Li QY; Zhao P; Ma ZQ; Yan ZL; Zheng GL; Yan Y; Tang XL; Zhou X
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 May; 24(5):403-412. PubMed ID: 34000769
[No Abstract] [Full Text] [Related]
4. Study protocol of a multicenter phase III randomized controlled trial investigating the efficiency of the combination of neoadjuvant chemotherapy (NAC) and neoadjuvant laparoscopic intraperitoneal hyperthermic chemotherapy (NLHIPEC) followed by R0 gastrectomy with intraoperative HIPEC for advanced gastric cancer (AGC): dragon II trial.
Beeharry MK; Ni ZT; Yang ZY; Zheng YN; Feng RH; Liu WT; Yan C; Yao XX; Li C; Yan M; Zhu ZG
BMC Cancer; 2020 Mar; 20(1):224. PubMed ID: 32183736
[TBL] [Abstract][Full Text] [Related]
5. Post-therapy pathologic tumor volume predicts survival in gastric cancer patients who underwent neoadjuvant chemotherapy and gastrectomy.
Tang X; He Q; Qu H; Sun G; Liu J; Gao L; Shi J; Ye J; Liang Y
BMC Cancer; 2019 Aug; 19(1):797. PubMed ID: 31409315
[TBL] [Abstract][Full Text] [Related]
6. [Exploration of potential beneficial people of neoadjuvant chemotherapy based on clinical staging in gastric cancer: a single center retrospective study].
Wang YK; Wang YC; Shan F; Tang L; Li ZY; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):152-157. PubMed ID: 32074795
[No Abstract] [Full Text] [Related]
7. [Prognostic analysis of neoadjuvant chemotherapy for locally advanced gastric cancer with propensity score matching method].
Peng L; Yang W; Zhang Z; Zhi C; Zhou X; Liu H; Hua Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1148-1153. PubMed ID: 30370514
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?
Reddavid R; Sofia S; Chiaro P; Colli F; Trapani R; Esposito L; Solej M; Degiuli M
World J Gastroenterol; 2018 Jan; 24(2):274-289. PubMed ID: 29375213
[TBL] [Abstract][Full Text] [Related]
9. [Key points of perioperative whole-process management for patients with advanced gastric cancer].
Zhu ZG
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Feb; 23(2):115-122. PubMed ID: 32074789
[TBL] [Abstract][Full Text] [Related]
10. Survival Benefit of Neoadjuvant Chemotherapy with S-1 Plus Docetaxel for Locally Advanced Gastric Cancer: A Propensity Score-Matched Analysis.
Kano M; Hayano K; Hayashi H; Hanari N; Gunji H; Toyozumi T; Murakami K; Uesato M; Ota S; Matsubara H
Ann Surg Oncol; 2019 Jun; 26(6):1805-1813. PubMed ID: 30977014
[TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant Chemotherapy for Gastric Cancer].
Yoshikawa T; Sato T; Yamada T; Aoyama T; Ogata T; Cho H
Gan To Kagaku Ryoho; 2016 Oct; 43(10):1157-1160. PubMed ID: 27760932
[TBL] [Abstract][Full Text] [Related]
12. [Timing of surgery after neoadjuvant chemotherapy for advanced gastric cancer].
Hu X
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Jun; 16(6):509-12. PubMed ID: 23801199
[TBL] [Abstract][Full Text] [Related]
13. A prospective multi-institutional validity study to evaluate the accuracy of clinical diagnosis of pathological stage III gastric cancer (JCOG1302A).
Fukagawa T; Katai H; Mizusawa J; Nakamura K; Sano T; Terashima M; Ito S; Yoshikawa T; Fukushima N; Kawachi Y; Kinoshita T; Kimura Y; Yabusaki H; Nishida Y; Iwasaki Y; Lee SW; Yasuda T; Sasako M;
Gastric Cancer; 2018 Jan; 21(1):68-73. PubMed ID: 28194522
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features and prognosis analysis of 21 gastric cancer patients with pathological complete response after neoadjuvant chemotherapy].
Peng L; Yang W; Zhang Z; Liu H; Hua Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Oct; 20(10):1168-1173. PubMed ID: 29130233
[TBL] [Abstract][Full Text] [Related]
15. Radiological criteria for selecting candidates for neoadjuvant chemotherapy for gastric cancer: an exploratory analysis from the PRODIGY study.
Kim HD; Lee JS; Yook JH; Ryu MH; Park YK; Kim JY; Kim YW; Oh SC; Kim JG; Cheong JH; Jeong O; Noh SH; Kang YK
Gastric Cancer; 2022 Jan; 25(1):170-179. PubMed ID: 34476643
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of neoadjuvant chemotherapy is different for type 4 and large type 3 gastric cancer.
Xu W; Wang L; Liu W; Li C; Yao X; Chen M; Yan M; Zhu Z; Yan C
Am J Surg; 2024 Feb; 228():273-278. PubMed ID: 37935616
[TBL] [Abstract][Full Text] [Related]
17. [Utilization of multimodal therapy concepts in stomach carcinoma in Germany].
Bösing NM; Heise JW; Röher HD
Zentralbl Chir; 2000; 125(4):341-7. PubMed ID: 10829314
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Significance of Stratification Using Pathological Stage and Response to Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
Matsuda S; Kawakubo H; Okamura A; Takahashi K; Toihata T; Takemura R; Mayanagi S; Takeuchi H; Watanabe M; Kitagawa Y
Ann Surg Oncol; 2021 Dec; 28(13):8438-8447. PubMed ID: 34142294
[TBL] [Abstract][Full Text] [Related]
19. Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy.
Feng D; Leong M; Li T; Chen L; Li T
World J Surg Oncol; 2015 Jan; 13():11. PubMed ID: 25634099
[TBL] [Abstract][Full Text] [Related]
20. A phase II study of neoadjuvant chemotherapy with S-1 and cisplatin for stage III gastric cancer: KUGC03.
Okabe H; Hata H; Ueda S; Zaima M; Tokuka A; Yoshimura T; Ota S; Kinjo Y; Yoshimura K; Sakai Y;
J Surg Oncol; 2016 Jan; 113(1):36-41. PubMed ID: 26604064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
